PrimeRFP SCOUT · Federal Contract Recompete Brief

W911NF26PA004Scalable biomanufacturing of sequence-defined — Aracodex Inc

Aracodex Inc holds $250K across 1 federal awards, concentrated at Department of Defense (DOD). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: SBA. Recompete timing centers on the Mar 25, 2027 PoP end — agencies typically plan 12–18 months ahead.

W6qk Acc-Apg Durham

Awarding office

Aracodex Inc

Recipient

Mar 25, 2027

PoP end

$250K

Obligated

$250K

Potential

541715

NAICS

AJ11

PSC

SBA

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Aracodex Inc — $90

Contract facts

SBA

Contract numberW911NF26PA004

AgencyW6qk Acc-Apg Durham

Awarding officeW6qk Acc-Apg Durham

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAracodex Inc

CAGE13EG8

UEIMM3WRNS8CF66

NAICS541715

PSCAJ11

Place of performanceMARLBOROUGH MA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startMar 26, 2026

PoP end (current)Mar 25, 2027

Obligated$250K

Current value$250K

Potential value$250K

SCALABLE BIOMANUFACTURING OF SEQUENCE-DEFINED ARAMID COPOLYMERS is a federal SBA award for W6qk Acc-Apg Durham held by Aracodex Inc. Estimated value $250K ($250K obligated). Current period of performance ends Mar 25, 2027. Last award drew 1 bidder. Place of performance: MARLBOROUGH MA.

SCALABLE BIOMANUFACTURING OF SEQUENCE-DEFINED ARAMID COPOLYMERS

Recompete timing

Public

● Expiring in 215 days

Current PoP ends Mar 25, 2027 (215 days remaining). Agencies typically plan 12–18 months ahead — at 7.1 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Aracodex Inc — $250K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$250K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W911NF26PA004?

W911NF26PA004 (Scalable biomanufacturing of sequence-defined) is a W6qk Acc-Apg Durham award with a potential value of $250K, currently held by Aracodex Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded W911NF26PA004?

W6qk Acc-Apg Durham awarded W911NF26PA004 to Aracodex Inc (potential $250K).

Who is the incumbent on W911NF26PA004?

Aracodex Inc is the incumbent with $250K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Mar 25, 2027.

When does Aracodex Inc’s W911NF26PA004 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 25, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 1, 2026 · refreshed monthlyLatest procurement action Apr 17, 2026